3DR Laboratories, LLC

3DR Laboratories, LLC is a provider of advanced 3D medical image post-processing solutions, enhancing diagnostic capabilities for healthcare facilities with innovative software and expert services. Founded in 2005 in Louisville, US, 3DR Laboratories specializes in medical imaging technology. The company was acquired by Accumen Inc. in October 2019.

The founders, Michael Lillig and Rob Falk, have a history of driving advancements in medical imaging. 3DR Labs specializes in advanced 3D medical image post-processing solutions, providing hospitals, radiology practices, and imaging centers with access to cutting-edge software and expert radiologic technologists. Their core offerings include comprehensive post-processing services for various imaging modalities, including Cardiac CT and MR studies, CTA, MRA, CTV, and advanced orthopedic image processing. These services are designed to enhance the diagnostic process, improve turnaround times, and streamline workflow within imaging departments.

Key to their approach is the utilization of artificial intelligence to automate processes and increase efficiency, catering to a diverse client base that includes over 1,800 health care facilities across the United States, with services available 24/7/365. The company's focus on collaboration and quality assurance allows it to address challenges in medical imaging effectively, making it a trusted partner in the healthcare sector. 3DR Labs generates revenue through a vendor-agnostic service platform that operates on a subscription basis, tailored to the needs of its healthcare clients. The firm provides its services through partnerships with hospitals and imaging centers, facilitating seamless integration of their advanced imaging solutions into existing workflows.

This model allows clients to access their extensive capabilities without the need for significant upfront investments in technology. Given the wide-ranging applications of their post-processing services, such as cardiac imaging and orthopedic studies, clients benefit from improved efficiency and quicker results in image analysis. Revenue is driven by the processing of over 600,000 patient cases annually, reflecting the robust demand for their innovative imaging solutions in the healthcare market. 3DR Laboratories plans to expand its product offerings with new solutions designed to enhance imaging capabilities and streamline healthcare workflows.

The firm aims to enter new geographic markets, particularly targeting areas with high healthcare demands by 2023. Recent funding of USD 7. 20 mn from Advantage Capital Partners will support these initiatives, facilitating the development of new products and the expansion of services to additional healthcare providers.